# Hereditary Angioedema

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £74,500,000
- Published: 9 February 2022
- Planned start: 1 July 2022
- Planned end: 31 December 2023
- Stage: open_tender
- Procurement category: goods
- Notice ID: a5f89f1b-088d-474b-a1ac-65f1ead8c3f0-508539
- OCID: ocds-b5fd17-da789255-31ab-43e7-81e3-936571ccbbd8

## Description

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema\. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 30 months\. Total maximum framework agreement including extension options will be nor more than 48 months\. Please refer to the offer documents for the list of purchasing points\.

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/a5f89f1b-088d-474b-a1ac-65f1ead8c3f0-508539)